Literatur zum Mikrobiom

Wissenschaftliche Informationen

Aktueller

Buchvorschlag

Einladung zur Veranstaltung zum Thema Mikrobiom

Intestinales Mikrobiom und Innere Medizin

Weitere Infos: UNI-MED Science,

2., neubearb. Auflage 2025, 176 Seiten, 33 Abb.

Das intestinale Mikrobiom repräsentiert aktuell eines der Topthemen, die im Fokus der modernen Humanmedizin stehen.

Autor: Prof. Dr. Eduard F. Stange (Hrsg.)

Mehr erfahren »

Aktuelle

Publikations-vorschläge

Clostridioides difficile-assoziierte Diarrhö – Klinische Studie zur adjuvanten Therapie mit Saccharomyces boulardii

Chitapanarux, Taned; Wiracha, Umaporn; Winichakoon, Poramed; Salee, Parichat; Traisathit, Patrinee (2025): Efficacy and safety of Saccharomyces boulardii as adjunct therapy with Vancomycin in treating Clostridioides difficile infection: A randomized controlled trial
Direkt zu Pub Med >>

INFORMATIONEN >>

Induktion kurzkettiger Fettsäuren durch Escherichia coli Nissle 1917

Ye, Zhenghao; Tan, Qinghai; Woltemate, Sabrina; Tan, Xinjie; Römermann, Dorothee; Grassl, Guntram A.; Vital, Marius; Seidler, Ursula and Kini, Archana. Escherichia coli Nissle Improves Short-Chain Fatty Acid Absorption and Barrier Function in a Mouse Model for Chronic Inflammatory Diarrhea.
Direkt zu Pub Med >>

INFORMATIONEN >>

Escherichia coli Stamm Nissle 1917: Stärkung der intestinalen Barriere bei Alzheimer-Patienten – Ergebnisse einer klinischen Studie

Loffredo, Lorenzo; Alfano, Alba Rosa; Ettorre, Evaristo; Desideri, Giovambattista; Carnevale, Roberto; Forte, Maurizio; Maglione, Vittorio; Bartimoccia, Simona; Castellani, Valentina; Totè, Chiara Maria; Pignatelli, Pasquale & Violi, Francesco. Effect of the probiotic Escherichia coli Nissle 1917 on serum levels of NADPH oxidase-2 and lipopolysaccharide in patients with Alzheimer’s disease
Direkt zu Pub Med >>

INFORMATIONEN >>

Literatur-Sammlung

Potential benefit of probiotic E. coli Nissle in term neonates.

Olbertz, Dirk; Proquitté, Hans; Patzer, Ludwig; Erler, Thomas; Mikolajczak, Alexsandra; Sadowska-Krawczenko, Iwona et al. (2023): Potential benefit of probiotic E. coli Nissle in term neonates.

The use of Escherichia coli strain Nissle 1917 shows promise for improving gastrointestinal and urinary health in dogs

Rudinsky, Adam J.; Harrison, Alistair; Shi, Baochen; Hardison, Rachael; Prinster, Tracy; Huang, Stella et al. (2023): The use of Escherichia coli strain Nissle 1917 shows promise for improving gastrointestinal and urinary health in dogs.

Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis

Park, Soo-Kyung; Kang, Sang-Bum; Kim, SangSoo; Kim, Tae Oh; Cha, Jae Myung; Im, Jong Pil et al. (2022): Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis.

Prophylaxis of acute respiratory infections via improving the immune system in late preterm newborns with E. coli strain Nissle 1917. A controlled pilot trial.

Aryayev, Mykola L.; Senkivska, Liudmyla I.; Bredeleva, Nataliya K.; Talashova, Irina V. (2018): Prophylaxis of acute respiratory infections via improving the immune system in late preterm newborns with E. coli strain Nissle 1917. A controlled pilot trial.

Effects of Escherichia coli strain Nissle 1917 on exercise-induced disruption of gastrointestinal integrity

Mooren, F. C.; Maleki, B. H.; Pilat, C.; Ringseis, R.; Eder, K.; Teschler, M.; Kruger, K. (2020): Effects of Escherichia coli strain Nissle 1917 on exercise-induced disruption of gastrointestinal integrity.

Probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)

Matthes, H.; Krummenerl, T.; Giensch, M.; Wolff, C.; Schulze, J. (2010): Clinical trial. Probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN).

Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents. An open-label pilot study.

Henker, J.; Müller, S.; Laass, M. W.; Schreiner, A.; Schulze, J. (2008): Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents. An open-label pilot study.

Probiotic Escherichia coli Nissle 1917 versus placebo for treating diarrhea of greater than 4 days duration in infants and toddlers.

Henker, J.; Laass, M. W.; Blokhin, B. M.; Maydannik, V. G.; Bolbot, Y. K.; Elze, M. et al. (2008): Probiotic Escherichia coli Nissle 1917 versus placebo for treating diarrhea of greater than 4 days duration in infants and toddlers.

The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers

Henker, J.; Laass, M.; Blokhin, B. M.; Bolbot, Y. K.; Maydannik, V. G.; Elze, M. et al. (2007): The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers.

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.

Kruis, W.; Fric, P.; Pokrotnieks, J.; Lukas, M.; Fixa, B.; Kascak, M. et al. (2004): Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis. A randomised trial.

Rembacken, B. J.; Snelling, A. M.; Hawkey, P. M.; Chalmers, D. M.; Axon, A. T. R. (1999): Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis. A randomised trial.

NF-KappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917. A novel effect of a probiotic bacterium.

Wehkamp, J.; Harder, J.; Wehkamp, K.; Wehkamp-von Meissner, B.; Schlee, M.; Enders, C. et al. (2004): NF-KappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917. A novel effect of a probiotic bacterium.

Behandlung der chronischen Obstipation mit physiologischen Escherichia-coli-Bakterien.

Möllenbrink, M.; Bruckschen, E. (1994): Behandlung der chronischen Obstipation mit physiologischen Escherichia-coli-Bakterien.

Chronische Obstipation, Vergleich von mikrobiologischer Therapie und Lactulose.

Bruckschen, E.; Horosiewicz, H. (1994): Chronische Obstipation, Vergleich von mikrobiologischer Therapie und Lactulose.

Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants.

Lodinova-Zadnikova, R.; Sonnenborn, U. (1997): Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants.

Literatur zum Mikrobiom

Wissenschaftliche Informationsschriften

L. Schulze, U. Sonnenborn, J. Schulze, M. Schiemann
Darmflora und chronisch entzündliche Darmerkrankungen
32 Seiten, 11 Abbildungen, 4 Tabellen.

L. Schulze, U. Sonnenborn, J. Schulze, M. Schiemann
Darmflora und chronisch entzündliche Darmerkrankungen; Pathophysiologische Bedeutung und therapeutische Konsequenzen.
32 Seiten, 14 Abbildungen, 4 Tabellen.

M. Schiemann, U. Sonnenborn, J. Schulze, H. Müller
125 Jahre E. coli — Bedeutung in Forschung und Medizin.
88 Seiten, 55 Abbildungen (ISBN 3-9811198-4-3).

U. Sonnenborn, M. Schiemann, H. Müller
Neue Forschungsergebnisse zu den Wirkmechanismen von E. coli Stamm Nissle 1917 (Mutaflor).
40 Seiten, 26 Abbildungen (ISBN 978-3-9811198-2-4).